Clal Insurance’s Oak Street Health, Inc. OSH Stock Holding History

Clal Insurance’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$425K	–	254
2021 Q3	$425K	Hold	10,000	–	–	﹤0.01%	173
2021 Q2	$586K	Buy	+10,000	New	+$595K	0.01%	167

Other funds holding OSH

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Clal Insurance's OSH Position: Q4 2021 in Review

Clal Insurance sold out of Oak Street Health, Inc. (OSH) in Q4 2021, closing a stake of 10,000 shares — an estimated $425K sold.

Clal Insurance first reported a position in OSH in Q2 2021 and held it in 2 quarters. The position peaked at $586K in Q2 2021. 222 funds tracked by Wall St. Rank hold OSH as of Q4 2021.

Clal Insurance reported no remaining Oak Street Health, Inc. position as of Q4 2021 after selling out during the quarter.
Clal Insurance sold 10,000 Oak Street Health, Inc. shares in Q4 2021, an estimated $425K.
Clal Insurance first reported a position in Oak Street Health, Inc. in Q2 2021 and held it in 2 quarters.
Clal Insurance's Oak Street Health, Inc. position peaked at $586K in Q2 2021.
222 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q4 2021.

Based on Clal Insurance's 13F filing for Q4 2021, filed 10 Feb 2022.